Spots Global Cancer Trial Database for Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments
Official Title: An Open-label, Multi-center Rollover Protocol for Continued Characterization of Safety and Tolerability for Subjects Who Have Participated in a Novartis-sponsored Spartalizumab Study as Single Agent or in Combination With Other Study Treatments
Study ID: NCT04058756
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to continue to assess safety and tolerability, and to allow continued access to study treatment for subjects already receiving spartalizumab as single agent or in combination with other study treatments.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Columbia University Medical Center New York Presbyterian, New York, New York, United States
Providence Portland Medical Center, Portland, Oregon, United States
MD Anderson Cancer Center Uni of Te MDACC, Houston, Texas, United States
Novartis Investigative Site, Leuven, , Belgium
Novartis Investigative Site, Liege, , Belgium
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Guangzhou, Guangdong, China
Novartis Investigative Site, Guangzhou, , China
Novartis Investigative Site, Brno, Czech Republic, Czechia
Novartis Investigative Site, Praha 4, , Czechia
Novartis Investigative Site, Lille, , France
Novartis Investigative Site, Lyon, , France
Novartis Investigative Site, Marseille, , France
Novartis Investigative Site, Marseille, , France
Novartis Investigative Site, Villejuif, , France
Novartis Investigative Site, Essen, , Germany
Novartis Investigative Site, Heidelberg, , Germany
Novartis Investigative Site, Jena, , Germany
Novartis Investigative Site, Ulm, , Germany
Novartis Investigative Site, High West, , Hong Kong
Novartis Investigative Site, Hong Kong, , Hong Kong
Novartis Investigative Site, Shatin New Territories, , Hong Kong
Novartis Investigative Site, Budapest, , Hungary
Novartis Investigative Site, Debrecen, , Hungary
Novartis Investigative Site, Debrecen, , Hungary
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Rozzano, MI, Italy
Novartis Investigative Site, Modena, MO, Italy
Novartis Investigative Site, Aviano, PN, Italy
Novartis Investigative Site, Siena, SI, Italy
Novartis Investigative Site, Napoli, , Italy
Novartis Investigative Site, Napoli, , Italy
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Leiden, , Netherlands
Novartis Investigative Site, Gdansk, , Poland
Novartis Investigative Site, Poznan, , Poland
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Hospitalet de LLobregat, Catalunya, Spain
Novartis Investigative Site, Valencia, Comunidad Valenciana, Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Zuerich, , Switzerland
Novartis Investigative Site, Taipei, , Taiwan
Novartis Investigative Site, Songkhla, Hat Yai, Thailand
Novartis Investigative Site, Bangkok, , Thailand
Novartis Investigative Site, Chiang Mai, , Thailand
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
